Postoperative Nausea and Vomiting Market
1 Study Coverage
1.1 Postoperative Nausea and Vomiting (PONV) Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million) Introduction
1.2 Global Postoperative Nausea and Vomiting (PONV) Outlook 2017 VS 2022 VS 2028
1.2.1 Global Postoperative Nausea and Vomiting (PONV) Market Size for the Year 2017-2028
1.2.2 Global Postoperative Nausea and Vomiting (PONV) Market Size for the Year 2017-2028
1.3 Postoperative Nausea and Vomiting (PONV) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Postoperative Nausea and Vomiting (PONV) in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Postoperative Nausea and Vomiting (PONV) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Postoperative Nausea and Vomiting (PONV) Market Dynamics
1.4.1 Postoperative Nausea and Vomiting (PONV) Industry Trends
1.4.2 Postoperative Nausea and Vomiting (PONV) Market Drivers
1.4.3 Postoperative Nausea and Vomiting (PONV) Market Challenges
1.4.4 Postoperative Nausea and Vomiting (PONV) Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Postoperative Nausea and Vomiting (PONV) by Type
2.1 Postoperative Nausea and Vomiting (PONV) Market Segment by Type
2.1.1 Serotonin Antagonists
2.1.2 Steroids
2.1.3 Dopamine Antagonists
2.1.4 NK-1 Receptor Antagonists
2.1.5 Non-pharmacologic Treatment
2.1.6 Others
2.2 Global Postoperative Nausea and Vomiting (PONV) Market Size by Type (2017, 2022 & 2028)
2.3 Global Postoperative Nausea and Vomiting (PONV) Market Size by Type (2017-2028)
2.4 United States Postoperative Nausea and Vomiting (PONV) Market Size by Type (2017, 2022 & 2028)
2.5 United States Postoperative Nausea and Vomiting (PONV) Market Size by Type (2017-2028)
3 Postoperative Nausea and Vomiting (PONV) by Application
3.1 Postoperative Nausea and Vomiting (PONV) Market Segment by Application
3.1.1 Hospital Pharmacies
3.1.2 Online Pharmacies
3.1.3 Retail Pharmacies
3.2 Global Postoperative Nausea and Vomiting (PONV) Market Size by Application (2017, 2022 & 2028)
3.3 Global Postoperative Nausea and Vomiting (PONV) Market Size by Application (2017-2028)
3.4 United States Postoperative Nausea and Vomiting (PONV) Market Size by Application (2017, 2022 & 2028)
3.5 United States Postoperative Nausea and Vomiting (PONV) Market Size by Application (2017-2028)
4 Global Postoperative Nausea and Vomiting (PONV) Competitor Landscape by Company
4.1 Global Postoperative Nausea and Vomiting (PONV) Market Size by Company
4.1.1 Top Global Postoperative Nausea and Vomiting (PONV) Companies Ranked by Revenue (2021)
4.1.2 Global Postoperative Nausea and Vomiting (PONV) Revenue by Player (2017-2022)
4.2 Global Postoperative Nausea and Vomiting (PONV) Concentration Ratio (CR)
4.2.1 Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Postoperative Nausea and Vomiting (PONV) in 2021
4.2.3 Global Postoperative Nausea and Vomiting (PONV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Postoperative Nausea and Vomiting (PONV) Headquarters, Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million) Type
4.3.1 Global Postoperative Nausea and Vomiting (PONV) Headquarters and Area Served
4.3.2 Global Postoperative Nausea and Vomiting (PONV) Companies Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Postoperative Nausea and Vomiting (PONV) Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Postoperative Nausea and Vomiting (PONV) Market Size by Company
4.5.1 Top Postoperative Nausea and Vomiting (PONV) Players in United States, Ranked by Revenue (2021)
4.5.2 United States Postoperative Nausea and Vomiting (PONV) Revenue by Players (2020, 2021 & 2022)
5 Global Postoperative Nausea and Vomiting (PONV) Market Size by Region
5.1 Global Postoperative Nausea and Vomiting (PONV) Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Postoperative Nausea and Vomiting (PONV) Market Size by Region (2017-2028)
5.2.1 Global Postoperative Nausea and Vomiting (PONV) Market Size by Region: 2017-2022
5.2.2 Global Postoperative Nausea and Vomiting (PONV) Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth 2017-2028
6.1.2 North America Postoperative Nausea and Vomiting (PONV) Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth 2017-2028
6.3.2 Europe Postoperative Nausea and Vomiting (PONV) Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth 2017-2028
6.4.2 Latin America Postoperative Nausea and Vomiting (PONV) Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Postoperative Nausea and Vomiting (PONV) Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Acacia Pharma
7.1.1 Acacia Pharma Company Details
7.1.2 Acacia Pharma Business Overview
7.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Introduction
7.1.4 Acacia Pharma Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
7.1.5 Acacia Pharma Recent Development
7.2 F. Hoffmann-La Roche
7.2.1 F. Hoffmann-La Roche Company Details
7.2.2 F. Hoffmann-La Roche Business Overview
7.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Introduction
7.2.4 F. Hoffmann-La Roche Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
7.2.5 F. Hoffmann-La Roche Recent Development
7.3 Novartis
7.3.1 Novartis Company Details
7.3.2 Novartis Business Overview
7.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Introduction
7.3.4 Novartis Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
7.3.5 Novartis Recent Development
7.4 Ani Pharmaceuticals
7.4.1 Ani Pharmaceuticals Company Details
7.4.2 Ani Pharmaceuticals Business Overview
7.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Introduction
7.4.4 Ani Pharmaceuticals Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
7.4.5 Ani Pharmaceuticals Recent Development
7.5 Camurus
7.5.1 Camurus Company Details
7.5.2 Camurus Business Overview
7.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Introduction
7.5.4 Camurus Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
7.5.5 Camurus Recent Development
7.6 Sanofi
7.6.1 Sanofi Company Details
7.6.2 Sanofi Business Overview
7.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Introduction
7.6.4 Sanofi Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
7.6.5 Sanofi Recent Development
7.7 Helsinn Holding
7.7.1 Helsinn Holding Company Details
7.7.2 Helsinn Holding Business Overview
7.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Introduction
7.7.4 Helsinn Holding Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
7.7.5 Helsinn Holding Recent Development
7.8 Eisai
7.8.1 Eisai Company Details
7.8.2 Eisai Business Overview
7.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Introduction
7.8.4 Eisai Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
7.8.5 Eisai Recent Development
7.9 Merck
7.9.1 Merck Company Details
7.9.2 Merck Business Overview
7.9.3 Merck Postoperative Nausea and Vomiting (PONV) Introduction
7.9.4 Merck Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
7.9.5 Merck Recent Development
7.10 GlaxoSmithKline
7.10.1 GlaxoSmithKline Company Details
7.10.2 GlaxoSmithKline Business Overview
7.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Introduction
7.10.4 GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
7.10.5 GlaxoSmithKline Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Postoperative Nausea and Vomiting (PONV) Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Postoperative Nausea and Vomiting (PONV) Market Trends
Table 3. Postoperative Nausea and Vomiting (PONV) Market Drivers
Table 4. Postoperative Nausea and Vomiting (PONV) Market Challenges
Table 5. Postoperative Nausea and Vomiting (PONV) Market Restraints
Table 6. Global Postoperative Nausea and Vomiting (PONV) Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Postoperative Nausea and Vomiting (PONV) Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Postoperative Nausea and Vomiting (PONV) Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Postoperative Nausea and Vomiting (PONV) Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Postoperative Nausea and Vomiting (PONV) Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Postoperative Nausea and Vomiting (PONV) Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Player, 2017-2022
Table 13. Global Postoperative Nausea and Vomiting (PONV) Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Postoperative Nausea and Vomiting (PONV) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postoperative Nausea and Vomiting (PONV) as of 2021)
Table 15. Top Players of Postoperative Nausea and Vomiting (PONV) in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Postoperative Nausea and Vomiting (PONV) Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Postoperative Nausea and Vomiting (PONV) Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Postoperative Nausea and Vomiting (PONV) Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Postoperative Nausea and Vomiting (PONV) Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Postoperative Nausea and Vomiting (PONV) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Postoperative Nausea and Vomiting (PONV) Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Postoperative Nausea and Vomiting (PONV) Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Postoperative Nausea and Vomiting (PONV) Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Postoperative Nausea and Vomiting (PONV) Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Postoperative Nausea and Vomiting (PONV) Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Postoperative Nausea and Vomiting (PONV) Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Postoperative Nausea and Vomiting (PONV) Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Acacia Pharma Company Details
Table 31. Acacia Pharma Business Overview
Table 32. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Product
Table 33. Acacia Pharma Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million)
Table 34. Acacia Pharma Recent Development
Table 35. F. Hoffmann-La Roche Company Details
Table 36. F. Hoffmann-La Roche Business Overview
Table 37. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Product
Table 38. F. Hoffmann-La Roche Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million)
Table 39. F. Hoffmann-La Roche Recent Development
Table 40. Novartis Company Details
Table 41. Novartis Business Overview
Table 42. Novartis Postoperative Nausea and Vomiting (PONV) Product
Table 43. Novartis Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million)
Table 44. Novartis Recent Development
Table 45. Ani Pharmaceuticals Company Details
Table 46. Ani Pharmaceuticals Business Overview
Table 47. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Product
Table 48. Ani Pharmaceuticals Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million)
Table 49. Ani Pharmaceuticals Recent Development
Table 50. Camurus Company Details
Table 51. Camurus Business Overview
Table 52. Camurus Postoperative Nausea and Vomiting (PONV) Product
Table 53. Camurus Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million)
Table 54. Camurus Recent Development
Table 55. Sanofi Company Details
Table 56. Sanofi Business Overview
Table 57. Sanofi Postoperative Nausea and Vomiting (PONV) Product
Table 58. Sanofi Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million)
Table 59. Sanofi Recent Development
Table 60. Helsinn Holding Company Details
Table 61. Helsinn Holding Business Overview
Table 62. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Product
Table 63. Helsinn Holding Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million)
Table 64. Helsinn Holding Recent Development
Table 65. Eisai Company Details
Table 66. Eisai Business Overview
Table 67. Eisai Postoperative Nausea and Vomiting (PONV) Product
Table 68. Eisai Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million)
Table 69. Eisai Recent Development
Table 70. Merck Company Details
Table 71. Merck Business Overview
Table 72. Merck Postoperative Nausea and Vomiting (PONV) Product
Table 73. Merck Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million)
Table 74. Merck Recent Development
Table 75. GlaxoSmithKline Company Details
Table 76. GlaxoSmithKline Business Overview
Table 77. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Product
Table 78. GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million)
Table 79. GlaxoSmithKline Recent Development
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
List of Figures
Figure 1. Postoperative Nausea and Vomiting (PONV) Product Picture
Figure 2. Global Postoperative Nausea and Vomiting (PONV) Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Postoperative Nausea and Vomiting (PONV) Market Size 2017-2028 (US$ Million)
Figure 4. United States Postoperative Nausea and Vomiting (PONV) Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Postoperative Nausea and Vomiting (PONV) Market Size 2017-2028 (US$ Million)
Figure 6. United States Postoperative Nausea and Vomiting (PONV) Market Share in Global 2017-2028
Figure 7. Postoperative Nausea and Vomiting (PONV) Report Years Considered
Figure 8. Product Picture of Serotonin Antagonists
Figure 9. Product Picture of Steroids
Figure 10. Product Picture of Dopamine Antagonists
Figure 11. Product Picture of NK-1 Receptor Antagonists
Figure 12. Product Picture of Non-pharmacologic Treatment
Figure 13. Product Picture of Others
Figure 14. Global Postoperative Nausea and Vomiting (PONV) Market Share by Type in 2022 & 2028
Figure 15. Global Postoperative Nausea and Vomiting (PONV) Market Size by Type (2017-2028) & (US$ Million)
Figure 16. Global Postoperative Nausea and Vomiting (PONV) Market Share by Type (2017-2028)
Figure 17. United States Postoperative Nausea and Vomiting (PONV) Market Share by Type in 2022 & 2028
Figure 18. United States Postoperative Nausea and Vomiting (PONV) Market Size by Type (2017-2028) & (US$ Million)
Figure 19. United States Postoperative Nausea and Vomiting (PONV) Market Share by Type (2017-2028)
Figure 20. Product Picture of Hospital Pharmacies
Figure 21. Product Picture of Online Pharmacies
Figure 22. Product Picture of Retail Pharmacies
Figure 23. Global Postoperative Nausea and Vomiting (PONV) Market Share by Application in 2022 & 2028
Figure 24. Global Postoperative Nausea and Vomiting (PONV) Market Size by Application (2017-2028) & (US$ Million)
Figure 25. Global Postoperative Nausea and Vomiting (PONV) Market Share by Application (2017-2028)
Figure 26. United States Postoperative Nausea and Vomiting (PONV) Market Share by Application in 2022 & 2028
Figure 27. United States Postoperative Nausea and Vomiting (PONV) Market Size by Application (2017-2028) & (US$ Million)
Figure 28. United States Postoperative Nausea and Vomiting (PONV) Market Share by Application (2017-2028)
Figure 29. North America Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate 2017-2028 (US$ Million)
Figure 30. U.S. Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. Canada Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Europe Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate 2017-2028 (US$ Million)
Figure 33. Germany Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. France Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. U.K. Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Italy Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Russia Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate 2017-2028 (US$ Million)
Figure 39. China Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Japan Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. South Korea Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. India Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Australia Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Taiwan Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Indonesia Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Thailand Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Malaysia Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Philippines Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Latin America Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate 2017-2028 (US$ Million)
Figure 50. Mexico Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Brazil Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Argentina Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate 2017-2028 (US$ Million)
Figure 54. Turkey Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. U.A.E Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 57. Acacia Pharma Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
Figure 58. F. Hoffmann-La Roche Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
Figure 59. Novartis Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
Figure 60. Ani Pharmaceuticals Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
Figure 61. Camurus Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
Figure 62. Sanofi Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
Figure 63. Helsinn Holding Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
Figure 64. Eisai Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
Figure 65. Merck Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
Figure 66. GlaxoSmithKline Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Industry Market Size
